GLP3-R
Blue Wave – Product Specifications Form: Lyophilized powder (freeze-dried for maximum stability and purity)
Available Vial Sizes: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg and 60 mg in a 3 mL vial
Retatrutide is a potent triple-agonist (tri-agonist) peptide analog that simultaneously targets receptors in the GLP-1, GIP, and glucagon families.
In laboratory research settings, Retatrutide is frequently studied for its multifaceted effects on metabolic pathways, receptor signaling related to weight management, amino acid sequence characteristics, and molecular stability under controlled analytical conditions.
Product Specifications
• Purity: ≥98% by HPLC
• Form: Lyophilized powder
• Intended Use: For laboratory and in-vitro research purposes only. Not for human consumption, therapeutic, or diagnostic use.
This high-purity research peptide is provided with strict quality controls to support reproducible results in metabolic, endocrinology, and peptide science investigations.